Market Tracker

07/22 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

3.43
Delayed Data
As of Jul 22
 +0.01 / +0.29%
Today’s Change
2.44
Today|||52-Week Range
10.60
-60.67%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close3.42
Today’s open3.42
Day’s range3.38 - 3.51
Volume227,379
Average volume (3 months)871,603
Market cap$181.0M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-42.71%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
ATHXAthersys Inc+0.03+1.42%
GLYCGlycoMimetics Inc+0.04+0.50%
NYMXNymox Pharmaceutical...+0.30+8.17%
ARGSArgos Therapeutics I...+0.19+2.87%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts